March 24 (Reuters) - Paradigm Biopharmaceuticals Ltd PAR.AX :
* EXTENDED ACCESS PROGRAM REMAINS ON-TRACK WITH PARADIGM EXPECTING TO REPORT RESULTS TO MARKET Q3 CY2020
March 24 (Reuters) - Paradigm Biopharmaceuticals Ltd PAR.AX :
* EXTENDED ACCESS PROGRAM REMAINS ON-TRACK WITH PARADIGM EXPECTING TO REPORT RESULTS TO MARKET Q3 CY2020